share_log

Oppenheimer Reiterates Outperform on Compugen, Maintains $8 Price Target

Benzinga ·  Feb 28, 2023 07:54

Oppenheimer analyst Mark Breidenbach reiterates Compugen (NASDAQ:CGEN) with a Outperform and maintains $8 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment